Skip to content
Homepage
Clinic directory

Clinics in Denver, Colorado

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Denver, CO

Stem Cell Therapy clinics in Denver

Denver supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through University of Colorado Hospital, UCHealth, and National Jewish Health, and stem cell practice in the area spans Cherry Creek, LoDo, and the Tech Center. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Colorado regulates physician practice through the Colorado Medical Board. There is no state-specific stem cell disclosure law, so federal 21 CFR Part 1271 rules apply. The state has a strong regenerative orthopedic research presence around Denver and Boulder. The 15 Denver clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Colorado Medical Board licensure checks.

16 Clinics, showing page 2 of 2

Denver Sports Medicine and Spine
MD on staff

Denver Sports Medicine and Spine

Denver, CO

Denver Sports Medicine and Spine, a regenerative medicine clinic in Denver, specializes in stem-cell therapy and platelet-rich plasma injections for musculoskeletal and sports injuries. The practice …

  • PRP Therapy
  • Arthritis Treatment
  • Stem Cell Therapy
15 30 50 results per page

Regulatory context

A note on Colorado's stem cell therapy rules.

Colorado cellular therapy clinics are governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without need for premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed for orthopedic, cosmetic, or neurologic conditions in Colorado are Section 351 biologics. The FDA expects compliance regardless of whether the cells are autologous.

  • Colorado Medical Practice Act, CRS Title 12, Article 240
    Establishes physician licensure and the Colorado Medical Board's authority over scope of practice and discipline.
  • Colorado Naturopathic Doctor Act, CRS Title 12, Article 250
    Defines registered naturopathic doctor scope, which excludes most injectable cellular procedures.
  • Colorado Pharmacy Practice Act, CRS Title 12, Article 280
    Regulates compounding pharmacies, including 503A standards relevant to biologic preparation.

The FDA has issued warning letters and inspectional observations to Colorado clinics marketing unapproved stem cell and exosome therapies. The Colorado Medical Board has disciplined physicians for unprofessional conduct related to misleading advertising and substandard care in regenerative procedures. Colorado has not produced a high-profile injunction comparable to the California SVF case, but federal scrutiny of Front Range and resort-area clinics has been steady. The Colorado Attorney General has authority under the Colorado Consumer Protection Act to pursue deceptive trade practice claims against providers making unsupported clinical claims.

Sources: fda.gov · leg.colorado.gov · dpo.colorado.gov

Stem Cell Therapy in Denver, answered.

Most stem cell therapies at private Denver clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. Colorado regulates physician practice through the Colorado Medical Board.

In the Denver metro, single-joint autologous bone marrow or adipose injections typically run $4,000 to $12,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $8,000 to $20,000, and full multi-session protocols can reach $15,000 to $40,000. Exosome add-ons range $3,500 to $7,500. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. Denver clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at University of Colorado Hospital, UCHealth, and National Jewish Health periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by Denver or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the Colorado Medical Board and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with federal 21 CFR 1271.

Available here

Other Treatments available in Denver

Explore statewide

Stem Cell Therapy in Colorado

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology